Trupanion Inc (NYSE:TRUP) Director Howard E. Rubin sold 75,000 shares of the company’s stock in a transaction on Monday, October 3rd. The shares were sold at an average price of $16.56, for a total value of $1,242,000.00. Following the completion of the sale, the director now owns 100,000 shares of the company’s stock, valued at $1,656,000. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Trupanion Inc (NYSE:TRUP) opened at 16.04 on Monday. Trupanion Inc has a one year low of $6.27 and a one year high of $17.68. The company’s 50-day moving average price is $15.89 and its 200-day moving average price is $14.01. The stock’s market capitalization is $465.40 million.
Trupanion (NYSE:TRUP) last released its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.03) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.06. The company earned $45.83 million during the quarter, compared to analyst estimates of $45.05 million. During the same period last year, the firm earned ($0.17) earnings per share. The business’s revenue was up 28.8% compared to the same quarter last year. Equities research analysts predict that Trupanion Inc will post ($0.22) EPS for the current year.
TRUP has been the subject of a number of research analyst reports. Lake Street Capital initiated coverage on Trupanion in a report on Tuesday, July 19th. They set a “buy” rating and a $18.00 price target for the company. RBC Capital Markets set a $18.00 price target on Trupanion and gave the stock a “buy” rating in a report on Tuesday, September 20th. Canaccord Genuity reiterated a “buy” rating and set a $19.00 price target on shares of Trupanion in a report on Thursday, August 4th. Stifel Nicolaus increased their price target on Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, August 3rd. Finally, Zacks Investment Research cut Trupanion from a “buy” rating to a “hold” rating in a report on Wednesday, July 27th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Trupanion currently has a consensus rating of “Buy” and an average price target of $15.75.
Institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC bought a new position in Trupanion during the second quarter worth $146,000. Metropolitan Life Insurance Co. NY acquired a new position in Trupanion during the second quarter valued at approximately $160,000. A.R.T. Advisors LLC acquired a new position in Trupanion during the second quarter valued at approximately $166,000. Alliancebernstein L.P. acquired a new position in Trupanion during the second quarter valued at approximately $168,000. Finally, Thompson Davis & CO. Inc. acquired a new position in Trupanion during the second quarter valued at approximately $181,000.
Trupanion Company Profile
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.